Enact (ACT) Q1 2026 Earnings Transcript

Enact Holdings delivered Q1 adjusted operating income of $172 million, or $1.21 per share, with NIW up 30% year over year to $13 billion and investment income up 12% to $71 million. Capital remains strong, with PMIERs sufficiency at 162% and $1.9 billion above requirements, while the board raised the quarterly dividend 14% to $0.24 and management reiterated roughly $500 million of 2026 capital returns. Credit trends were mixed but still solid: delinquencies fell 1% sequentially, cure rate rose to 54%, though losses incurred increased to $37 million and the loss ratio to 15%.

Analysis

Enact is quietly turning rate volatility into a moat, not a headwind. The key second-order effect is that short refinance windows are no longer just volume spikes; they are becoming a pricing and mix-management test that favors insurers with granular geo/borrower analytics. That dynamic should widen the gap versus smaller or less data-rich MI peers, because the winner is not the cheapest headline premium but the one that can underwrite through the volatility while protecting capital and still capturing refinance share.

The more interesting read-through is to the housing-finance ecosystem. If VantageScore 4.0 rolls out with PMIERs clarity, the industry could see a broader addressable borrower set, but ACT’s management is signaling that pricing will remain the gatekeeper. That makes FICO less of a direct beneficiary than a policy-setting input: the real upside belongs to the MI names that can rapidly re-map score bands into capital charges and premium grids. Over time, this should reinforce oligopoly economics in MI, while pressuring lenders and aggregators to adapt faster to new score regimes.

On risk, the market is likely underestimating how much the current book composition can mask future delinquency drift. Management already telegraphed that seasoning in newer purchase-heavy vintages could push delinquencies modestly higher over the next 1-3 quarters, even if actual claim severity stays contained. The longer-duration risk is not credit blowup; it’s margin compression if competition forces rate concessions while reserve releases normalize lower, reducing the earnings elasticity investors have gotten used to.

The stock screens as a capital-return story with embedded quality, but the multiple should hinge on whether buybacks/dividend growth can continue without relying on reserve release upside. If the market starts valuing ACT on normalized earnings rather than transitory credit tailwinds, the current setup is less about upside re-rating and more about sustained mid-teens ROE durability. That argues for owning it as a defensive compounder, not chasing it after a strong run unless macro rates re-ignite refinance penetration.

Key Decisions for Investors

• Long ACT common over the next 6-12 months on pullbacks: the setup is 13%+ ROE with explicit capital return support, but size modestly because normalization in reserve releases could cap near-term EPS upside.
• Pair trade: long ACT / short FICO for 3-6 months. ACT benefits directly from score-regime transition via pricing flexibility, while FICO faces the risk of being a policy input rather than an economic winner if PMIERs rework capital treatment.
• Use ACT calls, not stock, if rates resume falling into the spring selling season: 6-12 month upside comes from accelerated NIW and refinance penetration, but the thesis has clear time sensitivity.
• Fade aggressive upside in ACT after dividend/buyback headlines if the name trades to a premium multiple of normalized earnings. The risk/reward worsens once the market fully prices capital returns and stops paying for reserve-release durability.
• Watch for a relative-value long ACT vs regional banks with housing-heavy exposure (e.g., BAC, JPM mortgage unit sensitivity) if mortgage activity rebounds. ACT has cleaner capital return mechanics and less balance-sheet duration risk.